Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-032250)

Filing Details

Accession Number:: 0001209191-21-032250
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-13 07:05:12
Reporting Period:: 2021-05-12

Accepted Time:: 2021-05-13 07:05:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1579428	Axsome Therapeutics Inc.	AXSM	Pharmaceutical Preparations (2834)	454241907

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658379	Mark Coleman	C/O Axsome Therapeutics, Inc. 22 Cortlandt Street, 16Th Floor New York NY 10007		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-12	500	$58.15	420,998	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,100	Direct

Footnotes

Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
Represents additional shares held directly by the reporting person prior to May 12, 2021.